{
    "Trade/Device Name(s)": [
        "Dimension Vista\u2122M Carbon Dioxide (CO2) Flex\u00ae reagent cartridge",
        "Dimension Vista\u2122M Creatinine (CREA) Flex\u00ae reagent cartridge",
        "Dimension Vista\u2122M Lactate dehydrogenase (LDH) Flex\u00ae reagent cartridge"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K061238",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010206",
        "K925668",
        "K860021"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS",
        "CGX",
        "CFJ"
    ],
    "Summary Letter Date": "May 2, 2006",
    "Summary Letter Received Date": "May 3, 2006",
    "Submission Date": "May 2, 2005",
    "Regulation Number(s)": [
        "21CFR862.1160",
        "21CFR862.1125",
        "21CFR862.1440"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system",
        "Creatinine test system",
        "Lactate dehydrogenase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon dioxide",
        "Creatinine",
        "Lactate dehydrogenase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u2122M Integrated system"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dade Behring Dimension Vista\u2122M CO2, CREA, and LDH reagent cartridges for in vitro quantitative measurement of CO2, creatinine, and LDH on the Dimension Vista\u2122M system.",
    "Indications for Use Summary": "Quantitative measurement of carbon dioxide (in serum/plasma, for acid-base balance disorders), creatinine (in serum/plasma/urine, for renal disease diagnosis/treatment/dialysis monitoring), and lactate dehydrogenase activity (in serum/plasma, for diagnosis/treatment of liver, cardiac, and lung/kidney tumors).",
    "fda_folder": "Clinical Chemistry"
}